Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 2/20 | 0.51 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.51 |
| ▸ | CFD | P00746 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25374543 | 0.98 | PLA2G4B (0.55) | PLA2G4BTAAR1PPARDCYP4F2CYP4A11 | |
| SCHEMBL31457813 | 0.91 | PLA2G4B (0.61) | PLA2G4BPPARDCYP4F2CYP4A11CFD | |
| SCHEMBL30278809 | 0.90 | PLA2G4B (0.62) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL25081992 | 0.90 | PLA2G4B (0.62) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL31457802 | 0.89 | PLA2G4B (0.63) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL31457850 | 0.89 | PLA2G4B (0.63) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL31457781 | 0.89 | PLA2G4B (0.63) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL31457788 | 0.89 | PLA2G4B (0.63) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL25081989 | 0.88 | PLA2G4B (0.64) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 | |
| SCHEMBL25081990 | 0.88 | PLA2G4B (0.68) | PLA2G4BPPARDCYP4F2CYP4A11NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465811-B2 | Indoline compounds | LABORATOIRES FOURNIER S.A. (FR) | 2008-12-16 | — | — | US | disclosed |
| US-20080119465-A1 | Novel Indoline Compounds | LABORATORIES FOURNIER S.A. (FR) | 2008-05-22 | — | — | US | disclosed |
| US-4179511-A | Antibacterial 3-(5-tetrazolyl) penam compounds | PFIZER INC. (US) | 1979-12-18 | — | — | US | disclosed |
| US-4143039-A | ANTIBACTERIAL 3-(5-TETRAZOLYL)PENAM COMPOUNDS | PFIZER INC. (US) | 1979-03-06 | — | — | US | disclosed |
| US-4115385-A | PENICILLINS | PFIZER INC. (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119465-A1 | Novel Indoline Compounds | GPR119, INSR, IRS1 | PLA2G4B 2191/4885TAAR1 509/4885PPARD 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.